The deal value is $17B. Together with the Millipore unit Merck acquired for $7.2B in 2010 (#msg-47249493), SIAL will create an imposing life-sciences “tools” business under the Merck KGaA umbrella.
A CC was held today at 8am ET.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.